Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Statement of Cash Flows [Abstract]
Net loss	$ (5,547,609)	$ (7,298,869)
Adjustments to reconcile net loss with cash flows from operations:
Depreciation and amortization expense	624,419	600,978
Stock-based compensation	2,261,126	629,993
Extinguishment of note payable		985,481
Warrant exercise inducement expense		366,795
Amortization of debt discounts and issuance costs	237,435	214,668
Impairment losses		1,059,495
Forgiveness of note payable	(485,760)
Changes in operating assets and liabilities:
Accounts receivable	(127,930)	(23,217)
Net investment in direct financing lease	35,371	31,796
Other current assets and other assets	(308,479)	21,984
Inventory	113,870	374,366
Accounts payable and accrued expenses	644,649	1,056,433
Deferred revenue	223,393	28,810
Other liabilities	(47,809)
Net cash flows from operating activities	(2,377,324)	(1,951,287)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(78,325)	(2,394)
Investment in other assets including work in progress	(10,829)	(124,870)
Other assets		13,462
Net cash flows from investing activities	(89,154)	(113,802)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of convertible note payable		1,510,000
Payment of debt issuance costs		(104,800)
Proceeds from sale of common stock,		200,000
Proceeds from exercise of warrants		283,950
Proceeds from payroll protection loan	485,760	485,760
Payments on notes payable	(2,892)
Principal payments on capital lease obligation	(19,224)	(19,487)
Net cash flows from financing activities	463,644	2,355,423
Effect of Foreign Currencies	42,971	(42,465)
Net Change in Cash	(1,959,863)	247,869
Cash, Beginning of the Period	3,765,277	567,081
Cash, End of the Period	1,805,414	814,950
Supplemental Disclosure of Cash Flow Information:
Cash paid for interest	8,779	5,296
Cash paid for income taxes	9,853	12,466
Modification of warrants issued with convertible debt		95,223
Exchange of notes payable and accrued interest for convertible notes payable		2,662,000
Warrant exercise with a subscription receivable		965,033
Settlement of accounts payable with issuance of common stock		8,270
Conversion of convertible notes payable and accrued interest to common stock	6,232,340
Settlement of accounts payable with issuance of stock options	$ 349,376